Save Billions or Stick With Humira? Drug Brokers Steer Americans to the Costly Choice ...Middle East

Tennessee last year spent $48 million on a single drug, Humira — about $62,000 for each of the 775 patients who were covered by its employee health insurance program and receiving the treatment. So when nine Humira knockoffs, known as biosimilars, hit the market for as little as $995 a month, the opportunity for savings appeared ample and immediate. But it isn’t here yet. Makers of biosimilars must still work within a health care system in which basic economics rarely seems to hold sway. For real competition to take hold, the big pharmacy benefit managers, or PBMs, the companies that negotiate prices and set the prescription drug menu for 80% of insured patients in the Unite

Hence then, the article about save billions or stick with humira drug brokers steer americans to the costly choice was published today ( Tuesday 19/09/2023 - 12:01 PM ) and is available on KHN ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Save Billions or Stick With Humira? Drug Brokers Steer Americans to the Costly Choice )

Also on site :

• The Hollywood Reporter, Animation Is Film Festival Partner on Live Animation Roundtable With Bill Hader, Travis Knight, More
• ‘Street Fighter’ Cast Guide: All the WWE Stars, UFC Champs and Celebs Playing Video Game Fighters in the Live-Action Movie
• How Danny Bonaduce Is Turning Record Store Bargain Bins Into a Sweet Surprise for ‘Partridge Family’ Fans